Page last updated: 2024-08-16

phlorhizin and Diabetes Mellitus, Type 1

phlorhizin has been researched along with Diabetes Mellitus, Type 1 in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (18.18)	29.6817
2010's	7 (63.64)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Fralick, M; Kesselheim, AS	1
Akamine, T; Kawanami, D; Matoba, K; Nagai, Y; Sango, K; Takeda, Y; Utsunomiya, K; Yokota, T	1
Al-Sharea, A; Goldberg, IJ; Hu, Y; Huggins, LA; Murphy, AJ; Nagareddy, PR	1
Rieg, T; Vallon, V	1
Abcouwer, SF; Fort, PE; Gardner, TW; Jefferson, LS; Kimball, SR; Losiewicz, MK; Pennathur, S	1
Chang, CK; Cheng, JT; Cheng, KC; Juang, SW; Kou, DH; Liu, IM; Tong, YC	1
Bronson, SK; Dennis, MD; Jefferson, LS; Kimball, SR; Schrufer, TL	1
Hayashizaki, Y; Imamura, M; Kihara, R; Kobayashi, Y; Kurosaki, E; Noda, A; Qun, L; Sasamata, M; Shibasaki, M; Tahara, A; Takasu, T; Tomiyama, H; Yamajuku, D; Yokono, M	1
Chen, LJ; Chen, ZC; Cheng, J; Cheng, KC; Cheng, YZ; Li, Y	1
Evans, ML; Fan, X; Jacob, RJ; McCrimmon, RJ; Sherwin, RS; Shulman, GI; Zhu, Y	1
Hetenyi, G; Kovacevic, N; Lussier, B; Vranic, M	1

Reviews

2 review(s) available for phlorhizin and Diabetes Mellitus, Type 1

Article	Year
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy. International journal of molecular sciences, 2017, May-18, Volume: 18, Issue:5 Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Phlorhizin; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2017
Development of SGLT1 and SGLT2 inhibitors. Diabetologia, 2018, Volume: 61, Issue:10 Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Disease Models, Animal; Drug Design; Glucose; Humans; Intestinal Mucosa; Kidney; Mice; Mutation; Phlorhizin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2018

Article

Year

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.

International journal of molecular sciences, 2017, May-18, Volume: 18, Issue:5

Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Phlorhizin; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2017

Development of SGLT1 and SGLT2 inhibitors.

Diabetologia, 2018, Volume: 61, Issue:10

Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Disease Models, Animal; Drug Design; Glucose; Humans; Intestinal Mucosa; Kidney; Mice; Mutation; Phlorhizin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2018

Other Studies

9 other study(ies) available for phlorhizin and Diabetes Mellitus, Type 1

Article	Year
Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis. Pharmacoepidemiology and drug safety, 2020, Volume: 29, Issue:10 Topics: Clinical Trials as Topic; Data Collection; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Approval; Glycosides; Humans; Phlorhizin; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; United States; United States Food and Drug Administration	2020
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr Atherosclerosis, 2018, Volume: 271 Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cholesterol, Dietary; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Heparin; Hyperlipidemias; Lipoproteins; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Phlorhizin; Proteoglycans; Receptors, LDL; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin	2018
mTORC1-independent reduction of retinal protein synthesis in type 1 diabetes. Diabetes, 2014, Volume: 63, Issue:9 Topics: alpha-Crystallin A Chain; Animals; beta-Crystallin B Chain; Blood Glucose; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Eye Proteins; Hyperglycemia; Insulin; Intracellular Signaling Peptides and Proteins; Male; Mechanistic Target of Rapamycin Complex 2; Mice; Multiprotein Complexes; Phlorhizin; Phosphoproteins; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Rats; Receptor, Insulin; Regulatory-Associated Protein of mTOR; Retina; RNA, Ribosomal; TOR Serine-Threonine Kinases	2014
Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. International journal of experimental pathology, 2008, Volume: 89, Issue:4 Topics: Animals; Arecoline; Baroreflex; Cell Line; Cholinergic Agonists; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gene Expression; Glucose; Hyperglycemia; Hypotension; Insulin; Male; Phenylephrine; Phlorhizin; Rats; Rats, Wistar; Receptor, Muscarinic M2; RNA, Messenger	2008
Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes. The Journal of biological chemistry, 2011, Sep-30, Volume: 286, Issue:39 Topics: Acetylglucosamine; Adaptor Proteins, Signal Transducing; Animals; Blood Glucose; Carrier Proteins; Cell Cycle Proteins; Diabetes Mellitus, Type 1; Disease Models, Animal; Eukaryotic Initiation Factors; Glycosylation; Hyperglycemia; Liver; Mice; Mice, Transgenic; Phlorhizin; Phosphoproteins	2011
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo. Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:4 Topics: Animals; Blood Glucose; Carbohydrate Metabolism; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gastrointestinal Tract; Glucosides; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred ICR; Phlorhizin; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2012
Increase of ATP-sensitive potassium (K(ATP)) channels in the heart of type-1 diabetic rats. Cardiovascular diabetology, 2012, Jan-18, Volume: 11 Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Animals; ATP-Binding Cassette Transporters; Blood Glucose; Blood Pressure; Blotting, Northern; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diazoxide; Dose-Response Relationship, Drug; Down-Regulation; Free Radical Scavengers; Heart Rate; Hypoglycemic Agents; Insulin; KATP Channels; Male; Myocytes, Cardiac; Phlorhizin; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Receptors, Drug; RNA, Messenger; Streptozocin; Sulfonylurea Receptors; Time Factors; Up-Regulation	2012
AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. American journal of physiology. Endocrinology and metabolism, 2002, Volume: 283, Issue:5 Topics: Aminoimidazole Carboxamide; Animals; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Hypoglycemia; Hypoglycemic Agents; Insulin; Norepinephrine; Phlorhizin; Rats; Rats, Inbred BB; Ribonucleotides	2002
Glucoregulation in alloxan-diabetic dogs. Metabolism: clinical and experimental, 1986, Volume: 35, Issue:1 Topics: Animals; Blood Glucose; Catecholamines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dogs; Glucagon; Humans; Insulin; Liver; Phlorhizin	1986